Both in Pharmaceuticals
Apimeds Pharmaceuticals US vs Imunon
Over the past year APUS returned −84.9% and IMNN returned −82.3%; their daily moves had a correlation of 0.03.
APUS −84.9% IMNN −82.3%Growth of $1, one year, split-adjusted
| Metric | APUS | IMNN |
|---|---|---|
| Price | $3.07 | $0.8301 |
| Market cap | $4.6M | $21.3M |
| Today | +0.66% | −5.26% |
| 1 month | −38.8% | −37.8% |
| 6 months | — | −69.0% |
| Year to date | −81.3% | −78.2% |
| 1 year | — | −82.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | -$8.6M | -$169.7K |
| Dividend yield | — | — |
| Volatility (60d) | 265.0% | 91.5% |
| Short % of float | 0.9% | 1.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).